TI
CTMX icon

Tidal Investments’s CytomX Therapeutics CTMX Stock Holding History

Tidal Investments’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$925K Buy
246,697
+929
+0.4% +$3.55K ﹤0.01% 1790
2026
Q1 		$1.16M Buy
245,768
+200,005
+437% +$1.02M ﹤0.01% 1398
2025
Q4 		$195K Sell
45,763
-72,574
-61% -$276K ﹤0.01% 2011
2025
Q3 		$377K Sell
118,337
-194,513
-62% -$438K ﹤0.01% 1723
2025
Q2 		$710K Sell
312,850
-40,990
-12% -$66.1K ﹤0.01% 1190
2025
Q1 		$225K Sell
353,840
-28,689
-7% -$22.2K ﹤0.01% 1646
2024
Q4 		$394K Buy
382,529
+136,528
+55% +$147K ﹤0.01% 1494
2024
Q3 		$290K Sell
246,001
-12,000
-5% -$15.2K ﹤0.01% 1611
2024
Q2 		$315K Sell
258,001
-30,100
-10% -$59.9K ﹤0.01% 1508
2024
Q1 		$631K Sell
288,101
-18,006
-6% -$33.2K 0.01% 1092
2023
Q4 		$474K Sell
306,107
-12,004
-4% -$15.8K 0.01% 964
2023
Q3 		$410K Hold
318,111
– – 0.01% 934
2023
Q2 		$547K Hold
318,111
– – 0.02% 774
2023
Q1 		$480K Sell
318,111
-27,794
-8% -$62.8K 0.02% 780
2022
Q4 		$553K Buy
345,905
+34,590
+11% +$51.2K 0.02% 635
2022
Q3 		$451K Buy
311,315
+103,543
+50% +$159K 0.02% 598
2022
Q2 		$380K Buy
+207,772
New +$398K 0.01% 693

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Tidal Investments's CTMX Position: Q2 2026 in Review

Tidal Investments increased its CytomX Therapeutics (CTMX) stake by 0.38% in Q2 2026, buying an estimated $3.55K and bringing the position to 246,697 shares worth $925K. The position accounts for ﹤0.01% of the portfolio, ranked #1790.

Tidal Investments first reported a position in CTMX in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.16M in Q1 2026. 178 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • Tidal Investments held 246,697 shares of CytomX Therapeutics worth $925K as of Q2 2026.
  • Tidal Investments bought 929 CytomX Therapeutics shares in Q2 2026, an estimated $3.55K.
  • CytomX Therapeutics made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1790 holding.
  • Tidal Investments first reported a position in CytomX Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • Tidal Investments's CytomX Therapeutics position peaked at $1.16M in Q1 2026.
  • 178 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.